Postoperative Pain – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Postoperative pain throughout the body encompasses discomfort experienced across various areas, including joints, muscles, head, and limbs, often accompanied by restlessness, insomnia, sweating irregularities, fatigue, reduced appetite, and sometimes limb dysfunction. This type of pain typically emerges following significant surgical procedures, sometimes exacerbating pre-existing generalized body pain. Its intensity peaks within 24-48 hours post-surgery and gradually diminishes as the surgical site heals. In about 10% of surgical cases, acute postoperative pain can transition to chronic postsurgical pain, characterized by neuropathic features that are resistant to opioid treatment. Chronic body-wide pain, especially in the entire back, may also manifest, sometimes worsening acutely post-operation. Symptoms may include headaches, a stiff neck, joint pain, cold intolerance, mild fever, and specific pulse irregularities, notably at the Lung position. Inadequate management of postoperative pain can impede recovery, functional capabilities, and overall quality of life, elevating the risk of persistent pain and surgical complications. Pharmacological approaches to pain management may entail temporary escalation of opioid analgesics and the utilization of continuous regional block techniques immediately post-surgery.

·       Globally, a substantial number of major surgeries are performed annually, with the USA alone witnessing approximately 40 to 50 million procedures. A staggering 80% of surgical patients report experiencing postoperative pain, with 88% of them describing their pain levels as moderate, severe, or extreme.

 

Thelansis’s “Postoperative Pain Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Postoperative Pain treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

 

KOLs insights of Postoperative Pain across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Postoperative Pain Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Postoperative Pain – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Tags: Postoperative Pain, Postoperative Pain market outlook, Postoperative Pain competitive landscape, Postoperative Pain market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)